THALIDOMIDE AND LOVASTATIN AS A SALVAGE IMMUNOMODULATORY THERAPY IN PATIENTS WITH RELAPSED MULTIPLE MYELOMA

被引：0
|
作者：
Hus, M.
Adamczyk-Cioch, M. [1 ]
Jawniak, D. [1 ]
Grzasko, N. [1 ]
Morawska, M. [1 ]
Kozicka, J. [1 ]
Szostek, M. [2 ]
Helbig, G. [3 ]
机构：
[1] Med Univ, Dept Hematol & Bone Marrow Transplantat, Lublin, Poland
[2] Jagiellonian Univ, Coll Med, Dept Haematol, Krakow, Poland
[3] Silesian Med Univ, Katowice, Poland
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2010年 / 95卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1445
引用
收藏
页码：577 / 577
页数：1
相关论文
共 50 条
  • [1] Thalidomide, dexamethasone and lovastatin with autologous stem cell transplantation as a salvage immunomodulatory therapy in patients with relapsed and refractory multiple myeloma
    Marek Hus
    Norbert Grzasko
    Marta Szostek
    Andrzej Pluta
    Grzegorz Helbig
    Dariusz Woszczyk
    Maria Adamczyk-Cioch
    Dariusz Jawniak
    Wojciech Legiec
    Marta Morawska
    Justyna Kozinska
    Piotr Waciński
    Anna Dmoszynska
    Annals of Hematology, 2011, 90 : 1161 - 1166
  • [2] Thalidomide, dexamethasone and lovastatin with autologous stem cell transplantation as a salvage immunomodulatory therapy in patients with relapsed and refractory multiple myeloma
    Hus, Marek
    Grzasko, Norbert
    Szostek, Marta
    Pluta, Andrzej
    Helbig, Grzegorz
    Woszczyk, Dariusz
    Adamczyk-Cioch, Maria
    Jawniak, Dariusz
    Legiec, Wojciech
    Morawska, Marta
    Kozinska, Justyna
    Wacinski, Piotr
    Dmoszynska, Anna
    ANNALS OF HEMATOLOGY, 2011, 90 (10) : 1161 - 1166
  • [3] Salvage therapy with thalidomide in patients with advanced relapsed/refractory multiple myeloma
    Tosi, P
    Zamagni, E
    Cellini, C
    Ronconi, S
    Patriarca, F
    Ballerini, F
    Musto, P
    Di Raimondo, F
    Ledda, A
    Lauria, F
    Masini, L
    Gobbi, M
    Vacca, A
    Ria, R
    Cangini, D
    Tura, S
    Baccarani, M
    Cavo, M
    HAEMATOLOGICA, 2002, 87 (04) : 408 - 414
  • [4] Salvage therapy with thalidomide for patients with advanced relapsed/refractory multiple myeloma.
    Tosi, P
    Ronconi, S
    Zamagni, E
    Cellini, C
    Tura, S
    Cavo, M
    BLOOD, 2000, 96 (11) : 296B - 296B
  • [5] Lovastatin as salvage immumomodulatory therapy in patients with refractory and relapsed multipla myeloma.
    Hus, M
    Grzasko, N
    Jawniak, D
    Szostek, M
    Dmoszynska, A
    BLOOD, 2005, 106 (11) : 449A - 450A
  • [6] Thalidomide as salvage therapy for relapsed multiple myeloma after allogeneic stem cell transplantation
    Yakoub-Agha, I
    Mohty, M
    Attal, M
    Marit, G
    Bulabois, C
    Sotto, JJ
    Gratecos, N
    Rio, B
    Vernant, JP
    Facon, T
    Jouet, JP
    BONE MARROW TRANSPLANTATION, 2004, 33 : S156 - S156
  • [7] Thalidomide and dexamethasone as salvage therapy for refractory and relapsed myeloma.
    Palumbo, A
    Giaccone, L
    Bertola, A
    Bringhen, S
    Rus, C
    Triolo, S
    Pileri, A
    Boccadoro, M
    BLOOD, 2000, 96 (11) : 292B - 292B
  • [8] Salvage therapy for multiple myeloma with thalidomide and CED chemotherapy
    Moehler, TM
    Neben, K
    Benner, A
    Egerer, G
    Krasniqi, F
    Ho, AD
    Goldschmidt, H
    BLOOD, 2001, 98 (13) : 3846 - 3848
  • [9] Outcomes of VD-PACE With Immunomodulatory Agent as a Salvage Therapy for Relapsed/Refractory Multiple Myeloma
    Abdallah, Al-Ola
    Sigle, Monia
    Mohyuddin, Ghulam Rehman
    Coggins, Emily
    Remker, Cassie
    Shune, Leyla
    Mahmoudjafari, Zahra
    McGuirk, Joseph
    Ganguly, Siddhartha
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 (02): : E220 - E226
  • [10] Durability of response with thalidomide therapy for relapsed multiple myeloma
    Myers, B
    Jones, SG
    Dolan, G
    7TH ANNUAL MEETING OF THE EUROPEAN HAEMATOLOGY ASSOCIATION, 2002, : 259 - 262
12345